New marketing code for Indian drug companies favours the companies, critics say

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7495 (Published 8 November 2012)
Cite this as: BMJ 2012;345:e7495

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Mohuya Chaudhuri
  1. 1New Delhi

A new code of marketing practice for the drug industry is being drawn up by the Indian government aimed at stopping the provision of gifts to doctors by drug companies to promote their products.

It lays down that “No gifts, pecuniary advantages or benefits in kind may be supplied, offered or promised to persons qualified to prescribe or supply by a pharmaceutical company.” But it also says that “Companies may legitimately provide assistance that is directly related to the bona fide continuing education of the healthcare professionals.” …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL